MabVax Therapeutics (MBVX) Signs Pact with MSK to Develop Novel CAR T-Cell Based Anti-Cancer Immunotherapies – StreetInsider.com
|
MabVax Therapeutics (MBVX) Signs Pact with MSK to Develop Novel CAR T-Cell Based Anti-Cancer Immunotherapies
StreetInsider.com Under the new agreement, MabVax will provide funding to evaluate the efficacy of multiple CAR T-cell products incorporating several different antibody targeting sequences. The research program will evaluate in xenograft models of pancreatic and small … |
